Table II.

Demographic and laboratory data of patients stratified by outcome.

						SCr (µmol/l)			BUN (mmol/l)
Group	n	Age (years)	Initial PPC (mg/l)	Delay between poisoning and HP therapy (h)	Time of activated 1 charcoa HP therapy (h)	Prior to HP	After HP	At discharge	Prior to HP	After HP	At discharge
Death	7	40.43±13.53	7.75±2.81	6.71±1.82	18.29±2.43	68.00±8.72	85.43±19.42	181.43±55.34	5.16±1.57	7.17±2.06	11.74±2.51
Survival	12	40.33±12.56	2.50±1.35	7.63±2.04	12.42±4.34	53.00±16.45	65.91±23.90	76.92±27.97	4.68±1.13	5.44±2.00	8.26±3.18
P-value		0.988	<0.001	0.339	0.005	0.040	0.449	0.085	0.090	<0.001	0.024

BUN, blood urea nitrogen (normal range, 3.2–7.1 mmol/l); SCr, serum creatinine (normal range, 71–133 µmol/l); PPC, plasma paraquat concentration; HP, charcoal hemoperfusion.